| 摘要 |
The invention concerns the association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor (PPAR gamma ) agonist antidiabetic, pharmaceutical compositions containing said association and their use for preventing and/or treating type 2 diabetes and its complications. |
